Evommune, INC. (EVMN) — 10-Q Filings
All 10-Q filings from Evommune, INC.. Browse 1 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (1)
-
Evommune Narrows Loss on Revenue Jump, Secures $65M in New Funding
— Dec 11, 2025 Risk: high
Evommune, Inc. reported a net loss of $40.6 million for the nine months ended September 30, 2025, an improvement from the $46.1 million net loss in the prior ye
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX